TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 131 filers reported holding TRICIDA INC in Q3 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,408 | -98.5% | 15,751 | -0.4% | 0.00% | -100.0% |
| Q3 2022 | $166,000 | +9.9% | 15,808 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $151,000 | +73.6% | 15,584 | -5.4% | 0.00% | – |
| Q1 2021 | $87,000 | -25.0% | 16,479 | +0.3% | 0.00% | – |
| Q4 2020 | $116,000 | -24.2% | 16,437 | -2.8% | 0.00% | -100.0% |
| Q3 2020 | $153,000 | -67.8% | 16,908 | -2.2% | 0.00% | -50.0% |
| Q2 2020 | $475,000 | +67.3% | 17,292 | +33.8% | 0.00% | 0.0% |
| Q1 2020 | $284,000 | -45.0% | 12,924 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $516,000 | +21.1% | 13,670 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $426,000 | -22.3% | 13,785 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $548,000 | +24.3% | 13,882 | +21.6% | 0.00% | 0.0% |
| Q1 2019 | $441,000 | +143.6% | 11,416 | +48.5% | 0.00% | +100.0% |
| Q4 2018 | $181,000 | -23.6% | 7,685 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $237,000 | – | 7,744 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |